Navigation Links
SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
Date:5/19/2009

NATICK, Mass. and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive outcomes from a substudy of patients with left main coronary disease who were treated with the TAXUS(R) Express2(R) Paclitaxel-Eluting Coronary Stent System. SYNTAX-LE MANS is a substudy of the landmark SYNTAX trial, the first randomized, controlled clinical trial to compare percutaneous coronary intervention (PCI) using the TAXUS Stent to coronary artery bypass graft (CABG) surgery in patients with left main disease and/or significant narrowing of all three coronary arteries (three-vessel disease). The substudy data were presented by A. Pieter Kappetein, M.D., Ph.D., at the annual EuroPCR Scientific Program in Barcelona.

SYNTAX-LE MANS compares late angiographic and clinical outcomes in 263 patients with left main disease (149 treated with the TAXUS Stent and 114 treated with CABG). It is designed to assess 15-month patency (vessel openness) and the safety of stents and grafts in this high-risk population; it includes separate primary endpoints for each treatment arm. For PCI patients, the primary endpoint is the rate of long-term patency (defined here as <50% stenosis) of the treated lesion sites. For CABG patients, the primary endpoint is the ratio of obstructed/occluded grafts (defined here as greater than or equal to 50% stenosis) to total placed grafts. Results were presented separately for each group, and no formal statistical inferences between the two groups were made due to the different primary endpoints. Results were also broken out by left main lesion location, including distal and non-distal.

For those patients receiving a TAXUS Stent, the patency rate for the treated lesion was 92 percent. Restenosis was more common with distal lesions (90% patency) compared with non-distal
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. SYNTAX defines borders between CABG and PCI with TAXUS drug-eluting stents
2. State Audit of Blue Cross Blue Shield of Michigan Shows Company in Compliance with State and National Accounting Guidelines
3. McGraw Wentworth Mid-Market Group Benefits Survey Shows Health Care Costs Increasing at 6-Year Low of 5%
4. Autism in the UK costs more than $41 billion every year, shows new research
5. Sodium channel blocker shows promise as a potential treatment for cystic fibrosis
6. Transplant patients have worse cancer outcomes, analysis shows
7. Long-term study shows low oxygen levels in prostate tumors can predict recurrence
8. U.S. Study Shows Significant Improvement for Patients Suffering from Excessive Sweating with Topical Antiperspirant
9. New Discovery Shows Ancient Herb Fights Inflammation
10. Study shows chemotherapy improves survival among older breast cancer patients
11. UCLA study shows traumatic brain injury haunts children for years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 06, 2015 Established by the Arthritis ... the estimated 46 million Americans who suffer from arthritis. ... medications to alleviate their symptoms. Medicationdiscountcard.com is proud to ... patients money on the costs of these necessary prescriptions. ... to treat the pain and inflammation in the joints ...
(Date:5/6/2015)... 06, 2015 The Jefferson Awards ... to activating and celebrating public service, announced today ... Health, as an Outstanding Employee Volunteer Organization. Champions ... Awards Foundation, are dedicated to building a culture ... decade, Highmark Health has recognized employees who volunteer ...
(Date:5/6/2015)... Stout Industries is owned and operated by ... Texas fire departments. Stout Industries recently developed Fire-ground Injury ... to these fire safety devices. The departure lights are ... turned on. They light the area within 50 feet of ... the roof, preventing leg and ankle injuries. In 2013 ...
(Date:5/6/2015)... NH (PRWEB) May 06, 2015 Launch Corporation, ... has opened its new Nashua location at 17 Tanguay Avenue. ... will be the duo’s second Launch location in New England. ... their new team,” said Rob Arnold, founder, co-owner and CEO ... location and we look forward to seeing them continue to ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The SGNY ... New York City, announced today that it was named ... for a presentation video produced on behalf of Intarcia ... the category of motion graphics. , The competition sponsored ... received over 6000 entries from 22 countries. The ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4Health News:Kickstarter for FIRE Lights, the New Fire Safety Devices 2Health News:Jump Up and Celebrate: Launch Trampoline Park Opens in Nashua, NH 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2
... 23 Niutang Chemical, a leading,global manufacturer of ... Alan Turner to lead its new office in ... Ltd., Mr. Turner will,spearhead all of Nuitang,s sales ... acid. He will particularly focus on the company,s,fast-growing ...
... WellPoint, Inc. (NYSE:,WLP) today announced the appointment ... segment, effective July 8, 2008., In his ... WellPoint,s,Individual Business segment, which currently serves more than ... add the quality of experience and,strategic expertise that ...
... individuals had more advanced disease and were less likely ... News) -- Low socioeconomic status increases a cancer patient,s ... on almost 14,000 breast, prostate and colorectal patients in ... patients with low socioeconomic status had more advanced cancers ...
... discovery holds promise as a treatment target for this diverse ... Cancerous myeloma cells are so "addicted" to a gene known ... has revealed. , Reducing the activity of the gene by ... compromising other healthy activities, said scientists reporting in the current ...
... AFAM ) announced today that it is scheduled to ... of market on June 27,according to a preliminary list of ... B. Yarmuth, President and CEO of Almost Family, Inc., stated,"We ... end of June as,it will provide greater awareness and visibility ...
... Before Disaster ... Fans, Players and Coaches, CLEVELAND, June 23 The ... -- able to,detect hidden flaws or developed stress within Major ... -- will be introduced as,BatteryMate(TM) on June 27, 2008, at ...
Cached Medicine News:Health News:Niutang Recruits Seasoned Executive to Open U.K. Office 2Health News:WellPoint Appoints Raj G. Bal as President of Individual Business 2Health News:Poorer Patients Have Poorer Survival After Cancer Diagnosis 2Health News:One Gene May Be Key to Myeloma 2Health News:One Gene May Be Key to Myeloma 3Health News:Almost Family, Inc. Set to Join to Russell 2000(R) Index 2Health News:Bat Scan to the Rescue: New Clubhouse CT Scanner Helps Eliminate Exploding Bats 2Health News:Bat Scan to the Rescue: New Clubhouse CT Scanner Helps Eliminate Exploding Bats 3
(Date:5/6/2015)... 6, 2015 According to ... Isolation Market by Technology (Precipitation, Dialysis, Electrophoresis, Western ... (Instruments, Kits, Reagents, Resins) by Application & End ... MarketsandMarkets,  the global Protein Purification and Isolation Market ... and is expected to reach $ 6,370 Million ...
(Date:5/6/2015)... May 6, 2015   Symbiomix Therapeutics today ... and final tranche of a $41 million Series A ... 2 trial testing a single oral dose of SYM-1219 ... discussions with the U.S. Food and Drug Administration (FDA) ... planning to submit the Phase 2 trial as one ...
(Date:5/5/2015)... BARCELONA, Spain , May 6, 2015 ... and aspires to lead the European market in the ... Through this alliance ECUPHAR acquires all the assets ... the new organization in the coming weeks. Being both ... not been disclosed.      (Photo: http://photos.prnewswire.com/prnh/20150506/743274 ...
Breaking Medicine Technology:Protein Purification and Isolation Market Worth $6,370 Million by 2020 2Protein Purification and Isolation Market Worth $6,370 Million by 2020 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 4Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 2Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 3Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 4Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 5ECUPHAR Enters the Spanish and Southern European Markets Through ESTEVE 2
... International (OTC Bulletin Board: SNDZ ) said ... will be introduced in October to eye doctors and ... been planned by its Indian distributors, New Amsterdam Marketing ...  The company,s Pneumatic Trabeculoplasty (PNT), treatment is a cost-effective, ...
... one of the world,s leading research and advisory ... oncologists will be the most aggressive in adopting ... lower clinical trial requirements. According to Biosimilars ... on Biosimilar G-CSFs and MAbs in Oncology , ...
Cached Medicine Technology:Sunridge to Introduce Their PNT Treatment for Glaucoma to Medical Personnel in India 2Oncologists Will Be More Aggressive In Adopting Biosimilars Compared With Other Specialties 2
...
...
... FLEXILOG antimony pH catheters are designed for ... ,All catheters are number marked at 5cm ... ,More than sixteen individual models are available spanning ... single-use or multi-use models with one or two ...
... are designed using established technology providing ... benefits:, ,Working with pH catheters ... the multi-use catheter is used the ... to the skin.,NOTE: ,Medtronic pH measurement ...
Medicine Products: